NCT00002022已完成不适用
Treatment Program for Anemia in AIDS Patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Exclusion Criteria
- •Co-existing Condition:
- •Patients with the following are excluded:
- •Life expectancy < 3 months.
- •= or < grade 4 performance score.
- •AIDS-related dementia.
- •Uncontrolled hypertension.
- •Acute symptomatic opportunistic infection or other AIDS-defining illness.
- •Patients with the following are excluded:
- •Life expectancy < 3 months.
- •= or < grade 4 performance score.
- •AIDS-related dementia.
- •Uncontrolled hypertension.
- •Acute symptomatic opportunistic infection or other AIDS-defining illness.
- •Patients must have:
- •A clinical diagnosis of AIDS.
- •Hematocrit < 30 percent.
- •Endogenous serum erythropoietin level = or < 500 U/ml.
- •A life expectancy = or > 3 months.
- •> Grade 4 performance score.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCytopeniasHIV InfectionsNCT00002071Ortho Pharmaceuticals
已完成
不适用
A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease PatientsChronic DiseaseKidney DiseasesCardiovascular DiseasesNCT00563355Hospital Authority, Hong Kong66
已完成
不适用
se of erythropoietin for anaemia management, clearance of low and middle molecular weight uraemic toxins, quality of life and cost effectiveness of mid-dilution on-line haemodiafiltration compared to conventional low flux haemodialysisAnaemiaHaematological DisordersOther anaemiasISRCTN19844007Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)80
已完成
1 期
Systemic Erythropoietin Injection in Patients Having Optic AtrophyOptic AtrophyNCT04680143Alexandria University10
已完成
4 期
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)HIV InfectionsAnemiaNCT00317902Ortho Biotech Products, L.P.292